Do antidepressants really work?

Journal of Psychiatry and Neuroscience

Volumn 33, Issue 2, 2008, Pages 89-90

  Blier, Pierre ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antidepressive agents; Depression; Suicide; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ABSENTEEISM; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; PHYSICIAN; PUBLIC HEALTH; RISK BENEFIT ANALYSIS;

EID: 41149136680     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
2. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000;57:311-7.
3. Montgomery SA, Roberts A, Patel AG. Placebo-controlled efficacy of antidepressants in continuation treatment, Int Clin Psychopharmacol 1994;9(Suppl 1):49-53.
4. Keller MB, Trivedi MH, Thase ME, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry 2007;68:1246-56.
5. Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. STAR*D-Child Team. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006;295:1389-98.
6. Sanderson K, Andrews G. Common mental disorders in the workforce: recent findings from descriptive and social epidemiology. Can J Psychiatry 2006;51:63-75.
7. Angst J, Angst F, Gerber-Werder R, et al. Suicide in 406 mood disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005;9:279-300.
8. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25.
9. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87.
10. Klein DF. The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children. Neuropsychopharmacology 2006;31:689-99.
11. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry 2007;164:1029-34.